PharmGKB summary: peginterferon-α pathway.
Publication
, Journal Article
Shuldiner, SR; Gong, L; Muir, AJ; Altman, RB; Klein, TE
Published in: Pharmacogenet Genomics
September 2015
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Pharmacogenet Genomics
DOI
EISSN
1744-6880
Publication Date
September 2015
Volume
25
Issue
9
Start / End Page
465 / 474
Location
United States
Related Subject Headings
- Treatment Outcome
- Ribavirin
- Recombinant Proteins
- Polymorphism, Single Nucleotide
- Polyethylene Glycols
- Pharmacology & Pharmacy
- Interleukins
- Interferons
- Interferon-alpha
- Interferon alpha-2
Citation
APA
Chicago
ICMJE
MLA
NLM
Shuldiner, S. R., Gong, L., Muir, A. J., Altman, R. B., & Klein, T. E. (2015). PharmGKB summary: peginterferon-α pathway. Pharmacogenet Genomics, 25(9), 465–474. https://doi.org/10.1097/FPC.0000000000000158
Shuldiner, Scott R., Li Gong, Andrew J. Muir, Russ B. Altman, and Teri E. Klein. “PharmGKB summary: peginterferon-α pathway.” Pharmacogenet Genomics 25, no. 9 (September 2015): 465–74. https://doi.org/10.1097/FPC.0000000000000158.
Shuldiner SR, Gong L, Muir AJ, Altman RB, Klein TE. PharmGKB summary: peginterferon-α pathway. Pharmacogenet Genomics. 2015 Sep;25(9):465–74.
Shuldiner, Scott R., et al. “PharmGKB summary: peginterferon-α pathway.” Pharmacogenet Genomics, vol. 25, no. 9, Sept. 2015, pp. 465–74. Pubmed, doi:10.1097/FPC.0000000000000158.
Shuldiner SR, Gong L, Muir AJ, Altman RB, Klein TE. PharmGKB summary: peginterferon-α pathway. Pharmacogenet Genomics. 2015 Sep;25(9):465–474.
Published In
Pharmacogenet Genomics
DOI
EISSN
1744-6880
Publication Date
September 2015
Volume
25
Issue
9
Start / End Page
465 / 474
Location
United States
Related Subject Headings
- Treatment Outcome
- Ribavirin
- Recombinant Proteins
- Polymorphism, Single Nucleotide
- Polyethylene Glycols
- Pharmacology & Pharmacy
- Interleukins
- Interferons
- Interferon-alpha
- Interferon alpha-2